Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Reprint Policy Expands To Clinical Practice Guidelines, Medical Reference Texts

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA has revised, but not loosened, its 2009 final guidance on good reprint practices for distribution of journal articles on unapproved uses of approved drugs and devices.


Related Content

FDA’s New Criminal Investigations Chief Wants Global Reach
FDA’s New Criminal Investigations Chief Wants Global Reach
FDA Guidance On Health Care Economic Data Is Coming In 2015
Clinical Data Transparency Would Counter-Balance Off-Label Promotion – NEJM
Journal Reprints: Risk-Mitigating Info Should Be “At Least As Persuasive” As Existing Sources
Journal Reprint Guidance: Industry And FDA Still At Odds Over Off-Label Information
Acknowledging Caronia: FDA Takes The First Step To Rethinking Off-Label Policy
Off-Label Enforcement, Not Promotion, May See First Changes After Free Speech Ruling
Off-Label Use Discussions Should Stay Off-line, FDA Draft Guidance Says
Off-Label Reprint Guidance: “Definitely Improved,” But Will Waxman Fight On?


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts